La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?

Identifieur interne : 002F82 ( Main/Exploration ); précédent : 002F81; suivant : 002F83

Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?

Auteurs : Kay Castagnoli [États-Unis] ; Thangaraju Murugesan [États-Unis]

Source :

RBID : Pascal:04-0194095

Descripteurs français

English descriptors

Abstract

The potential neuroprotective properties of monoamine oxidase B (MAO-B) inhibitors have been of interest in part because of the role that this enzyme plays in the bioactivation of the parkinsonian inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Interestingly, tobacco smokers have lowered levels of brain and blood platelet MAO-B activity and a well documented lowered incidence of Parkinson's disease (PD) compared to non-smokers. This correlation has led to the intriguing question of whether there are possible relationships between smoking, MAO-B activity and PD. Recent studies have evaluated specific components of tobacco smoke for their MAO inhibiting and neuroprotective properties. This chapter summarizes the relevant literature relating to the basic questions in these areas. We have undertaken studies to identify possible inhibitors of MAO-B in the tobacco leaf and tobacco smoke and have evaluated one such compound in the MPTP PD mouse model. In this chapter we report on the results of these studies and present a discussion of potential avenues of research and their implication with respect to PD, smoking and monoamine oxidase.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?</title>
<author>
<name sortKey="Castagnoli, Kay" sort="Castagnoli, Kay" uniqKey="Castagnoli K" first="Kay" last="Castagnoli">Kay Castagnoli</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Harvey W Peters Center for the Study of Parkinson's Disease, Department of Chemistry, Virginia Tech</s1>
<s2>Blacksburg, VA 24061-0212</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Murugesan, Thangaraju" sort="Murugesan, Thangaraju" uniqKey="Murugesan T" first="Thangaraju" last="Murugesan">Thangaraju Murugesan</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Harvey W Peters Center for the Study of Parkinson's Disease, Department of Chemistry, Virginia Tech</s1>
<s2>Blacksburg, VA 24061-0212</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">04-0194095</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0194095 INIST</idno>
<idno type="RBID">Pascal:04-0194095</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E42</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000592</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C00</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000C00</idno>
<idno type="wicri:doubleKey">0161-813X:2004:Castagnoli K:tobacco:leaf:smoke</idno>
<idno type="wicri:Area/Main/Merge">003400</idno>
<idno type="wicri:Area/Main/Curation">002F82</idno>
<idno type="wicri:Area/Main/Exploration">002F82</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?</title>
<author>
<name sortKey="Castagnoli, Kay" sort="Castagnoli, Kay" uniqKey="Castagnoli K" first="Kay" last="Castagnoli">Kay Castagnoli</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Harvey W Peters Center for the Study of Parkinson's Disease, Department of Chemistry, Virginia Tech</s1>
<s2>Blacksburg, VA 24061-0212</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Murugesan, Thangaraju" sort="Murugesan, Thangaraju" uniqKey="Murugesan T" first="Thangaraju" last="Murugesan">Thangaraju Murugesan</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Harvey W Peters Center for the Study of Parkinson's Disease, Department of Chemistry, Virginia Tech</s1>
<s2>Blacksburg, VA 24061-0212</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Neurotoxicology : (Park Forest South)</title>
<title level="j" type="abbreviated">Neurotoxicology : (Park Forest South)</title>
<idno type="ISSN">0161-813X</idno>
<imprint>
<date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neurotoxicology : (Park Forest South)</title>
<title level="j" type="abbreviated">Neurotoxicology : (Park Forest South)</title>
<idno type="ISSN">0161-813X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Genetic linkage</term>
<term>MAO inhibitor</term>
<term>Neurology</term>
<term>Neuroprotection</term>
<term>Parkinson disease</term>
<term>Plant leaf</term>
<term>Tobacco smoke</term>
<term>Tobacco smoking</term>
<term>Toxicology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Fumée tabac</term>
<term>Feuille végétal</term>
<term>Tabagisme</term>
<term>Parkinson maladie</term>
<term>IMAO</term>
<term>Neuroprotection</term>
<term>Liaison génétique</term>
<term>Neurologie</term>
<term>Toxicologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Tabagisme</term>
<term>Neurologie</term>
<term>Toxicologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The potential neuroprotective properties of monoamine oxidase B (MAO-B) inhibitors have been of interest in part because of the role that this enzyme plays in the bioactivation of the parkinsonian inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Interestingly, tobacco smokers have lowered levels of brain and blood platelet MAO-B activity and a well documented lowered incidence of Parkinson's disease (PD) compared to non-smokers. This correlation has led to the intriguing question of whether there are possible relationships between smoking, MAO-B activity and PD. Recent studies have evaluated specific components of tobacco smoke for their MAO inhibiting and neuroprotective properties. This chapter summarizes the relevant literature relating to the basic questions in these areas. We have undertaken studies to identify possible inhibitors of MAO-B in the tobacco leaf and tobacco smoke and have evaluated one such compound in the MPTP PD mouse model. In this chapter we report on the results of these studies and present a discussion of potential avenues of research and their implication with respect to PD, smoking and monoamine oxidase.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Virginie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Virginie">
<name sortKey="Castagnoli, Kay" sort="Castagnoli, Kay" uniqKey="Castagnoli K" first="Kay" last="Castagnoli">Kay Castagnoli</name>
</region>
<name sortKey="Murugesan, Thangaraju" sort="Murugesan, Thangaraju" uniqKey="Murugesan T" first="Thangaraju" last="Murugesan">Thangaraju Murugesan</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F82 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F82 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:04-0194095
   |texte=   Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024